跳至主要内容
临床试验/NCT02127294
NCT02127294已完成不适用

Effectiveness and Safety of Transcatheter Patent Foramen Ovale Closure for Migraine

Yi Yang1 个研究点 分布在 1 个国家目标入组 258 人开始时间: 2013年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
258
试验地点
1
主要终点
Contrast-enhanced Transcranial Doppler

研究概览

简要总结

The purpose of the study is to evaluate effectiveness and safety of transcatheter patent foramen ovale closure for migraine.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical history of migraine diagnosed by a neurologist according to the International Classification of Headache Disorders
  • Transcranial Doppler evidence of right-to-left shunt(RLS) and echocardiographic evidence of PFO,of which the degree is moderate to large RLS
  • Subjects who have not responded to or cannot take common migraine preventive medications
  • Willing to participate in follow-up visits
  • Additional Inclusion Criteria:
  • Transcatheter closure group: Closure of PFO is performed
  • Contrast group: Subjects who meet the Inclusion Criteria, but refuse to undergo closure procedure

排除标准

  • Seizure disorder
  • Other organic central nervous system disease
  • Subjects whose headaches are other than migraine, such as a result of traumatic head or neck injury
  • Evidence of alcohol, drug or substance abuse within the previous year
  • Additional Exclusion Criteria for Transcatheter closure group:
  • Subjects with intracardiac thrombus or tumor
  • Subjects who have an acute or recent (within 6 months) myocardial infarction or unstable angina
  • Subjects with left ventricular aneurysm or akinesis
  • Subjects with atrial fibrillation/atrial flutter (chronic or intermittent)
  • Subjects with another source of right to left shunt identified at baseline, including an atrial septal defect and/or fenestrated septum
  • Subjects with contraindication to aspirin or Clopidogrel therapy
  • Pregnant or desire to become pregnant within the next year

结局指标

主要结局

Contrast-enhanced Transcranial Doppler

时间窗: within one year period

Patients in transcatheter closure group are required to perform contrast-enhanced Transcranial Doppler at 1 month, 3 month, 6 month and 1 year after closure, respectively.

次要结局

  • Headache Impact Test-6(within one year period, at least 3 months)

研究者

发起方
Yi Yang
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Yi Yang

Associated Dean of First Hospital of Jilin University

The First Hospital of Jilin University

研究点 (1)

Loading locations...

相似试验